Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2025)
Historic Amortizatization of Intangibles for Cartesian Therapeutics (RNAC) over the last 10 years, with Q3 2025 value amounting to $192000.0.
- Cartesian Therapeutics' Amortizatization of Intangibles fell 7059.72% to $192000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 4495.99%. This contributed to the annual value of $2.4 million for FY2024, which is 3893.96% up from last year.
- Per Cartesian Therapeutics' latest filing, its Amortizatization of Intangibles stood at $192000.0 for Q3 2025, which was down 7059.72% from $187000.0 recorded in Q2 2025.
- Cartesian Therapeutics' Amortizatization of Intangibles' 5-year high stood at $671000.0 during Q4 2024, with a 5-year trough of $184000.0 in Q1 2025.
- Over the past 5 years, Cartesian Therapeutics' median Amortizatization of Intangibles value was $339000.0 (recorded in 2022), while the average stood at $379473.7.
- Per our database at Business Quant, Cartesian Therapeutics' Amortizatization of Intangibles surged by 4977.06% in 2024 and then crashed by 7059.72% in 2025.
- Over the past 5 years, Cartesian Therapeutics' Amortizatization of Intangibles (Quarter) stood at $287000.0 in 2021, then soared by 41.81% to $407000.0 in 2022, then increased by 16.95% to $476000.0 in 2023, then soared by 40.97% to $671000.0 in 2024, then tumbled by 71.39% to $192000.0 in 2025.
- Its Amortizatization of Intangibles was $192000.0 in Q3 2025, compared to $187000.0 in Q2 2025 and $184000.0 in Q1 2025.